Genesis IBRC Share Price | Genesis IBRC Stock Screener
GENESIS
Biotechnology
Share Price BSE
₹85.36
▲
4.06 (4.99%)
As of April 20, 2026, the Genesis IBRC share price (BSE: GENESIS) is ₹85.36, up 4.99% from the previous close, with shares trading between ₹85.36 and ₹85.36, and a 52-week range of ₹20.21–₹184.90.
Check GENESIS price range for the annual price range and momentum.
Use the Genesis IBRC stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Genesis IBRC Market Cap
₹386.27 Cr.
GENESIS P/E Ratio (TTM)
-
Genesis IBRC P/B Ratio
9.06
EPS (TTM)
₹-0.03
Dividend Yield
-
Debt to Equity
0.15
GENESIS 52 Week High
₹184.90
Genesis IBRC 52 Week Low
₹20.21
Operating Margin
-
Profit Margin
-
GENESIS Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹12.00
Total Equity
₹10.00
Genesis IBRC Share Price Chart
Screen Genesis IBRC share price with an interactive chart. Analyse GENESIS price trends and volatility across different timeframes.
Genesis IBRC Company Profile - Fundamental Screener
Screen Genesis IBRC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GENESIS shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE194N01016
Genesis IBRC Balance Sheet Screener
Screen GENESIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2018 |
|---|---|
| Assets | |
| Total Assets | 12 |
| Current Assets | 7 |
| Fixed Assets | 2 |
| Liabilities | |
| Total Liabilities | 0 |
| Current Liabilities | 0 |
| Non-Current Liabilities | 0 |
| Shareholders' Equity | |
| Total Equity | 10 |
| Share Capital | 13 |
| Reserves & Surplus | -3 |
Genesis IBRC Income Statement Screener - Profit & Revenue Analysis
Screen Genesis IBRC income statement and profit fundamentals.
Analyze GENESIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genesis IBRC share price evaluation.
| Item | None-None | 2018-March |
|---|---|---|
| Revenue | 0 | 4 |
| Expenses | 0 | 4 |
| EBITDA | 0 | 0 |
| Operating Profit % | 0.00% | 4.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 0 | 0 |
| Tax | 0 | 0 |
| Net Profit | 0 | 0 |
| EPS | 0.00 | -0.03 |
Genesis IBRC Cash Flow Screener - Liquidity Fundamentals
Screen GENESIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2018-March |
|---|---|
| Operating Activities | 2 |
| Investing Activities | -5 |
| Financing Activities | 3 |
| Net Cash Flow | 0 |
Genesis IBRC Shareholding Pattern Screener
See Genesis IBRC shareholding pattern with promoter, FII, and DII holdings.
Check Genesis IBRC promoter holding and ownership changes for GENESIS on TickJournal.
| Item | 2026-Apr | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.35% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% | 11.33% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.19% | 32.00% | 32.00% | 32.00% | 25.08% | 49.31% | 49.31% | 49.31% |
| Other Holding | 16.46% | 56.66% | 56.66% | 56.66% | 63.59% | 39.36% | 39.36% | 39.36% |
| Shareholder Count | 1,947 | 1,747 | 1,731 | 1,736 | 1,855 | 1,749 | 1,750 | 1,751 |
Genesis IBRC Share Dividend Screener - Share Yield Analysis
Check Genesis IBRC dividend history with payout and yield data.
View Genesis IBRC dividend details including ex-dates and amounts for GENESIS stock.
Genesis IBRC Stock Index Membership
See which indices include Genesis IBRC stock.
Check GENESIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genesis IBRC Market Events Screener - Corporate Actions
Get Genesis IBRC corporate actions including splits, bonuses, and buybacks.
Check Genesis IBRC stock events that may affect GENESIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.97% | ||
| Annual General Meeting | NA | 79.36% | ||
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -14.24% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 3.95% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 15.73% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 4.98% |
| 2018-01-12 | 2018-01-12 | Change Of Name | NA | - |
Genesis IBRC Competitors Screener - Peer Comparison
Screen GENESIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 40,626 | 83.45 | 1,930 | 30.15% | 451 | 62.37 |
| Advanced Enzyme Tech | 3,375 | 22.22 | 670 | 1.44% | 134 | 64.81 |
| Genesis IBRC | 386 | -1626.00 | 4 | % | 0 | 41.47 |
| Vivo Bio Tech | 64 | 14.36 | 52 | 13.19% | 7 | 67.76 |
| Shree Ganesh Bio-Tech | 27 | -69.00 | 24 | 14.55% | 0 | 68.72 |
| Genomic Valley Biotech | 9 | -190.00 | 1 | 300.00% | 0 | 54.08 |
Genesis IBRC Company Announcements - News Screener
Screen GENESIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-24 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-08 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-04-08 | Announcement under Regulation 30 (LODR)-Change in Corporate Office Address | - |
| 2026-04-08 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-04-08 | Board Meeting Outcome for Outcome Of Board Meeting For Appointment Of Company Secretary Compliance Officer And KMP. Also For Situation Of Corporate Office And Keeping Books Of Accounts At The Place Other Than Registered Office. | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-26 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-13 | The Company Has Received In-Principle Approval From BSE Limited For Issue Of Equity Shares On Preferential Basis. | - |
| 2026-03-12 | Announcement under Regulation 30 (LODR)-Change of Company Name | - |
| 2026-03-06 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-03-06 | Adoption Of New Line Of Business By The Company. | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-03-06 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-02-14 | Results For The Quarter Ended On December 31 2025. | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 In Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-11 | Board Meeting Intimation for Approving Results For The Quarter Ended On December 31 2025 And Other Matters. | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |